EAHAD 2027 – 20th Annual Congress of the European Association for Haemophilia and Allied Disorders, Brussels

Name: EAHAD 2027 – 20th Annual Congress of the European Association for Haemophilia and Allied Disorders, Brussels
Start: 2027-02-02
End: 2027-02-05
Location: Tour & Taxis (the Sheds), Avenue du Port 86C

Key facts

Venue: Tour & Taxis (the Sheds), Avenue du Port 86C
Organiser: European Association for Haemophilia and Allied Disorders (EAHAD)
Edition: 20th Annual Congress (anniversary edition)
Congress Presidents: Cedric Hermans and Thierry VandenDriessche
Audience: clinicians, researchers, nurses, physiotherapists and psychosocial professionals working in bleeding disorders
Programme extras: Allied Health Professionals Day, Ultrasound Workshop

EAHAD 2027 is the 20th Annual Congress of the European Association for Haemophilia and Allied Disorders, a four-day meeting on inherited and acquired bleeding disorders. The anniversary edition comes to Brussels, the city where EAHAD has its headquarters, and takes place at Tour & Taxis, an early-1900s goods warehouse site redeveloped into an event venue.

The scientific programme covers the organisation of haemophilia treatment centres, innovative therapeutic strategies, laboratory advances, musculoskeletal health, gene therapy and gene editing, von Willebrand disease and rare bleeding disorders. The organizers present it as relevant to all subspecialties of the field, from laboratory science and treatment innovation to physiotherapy, psychosocial care and the daily running of a treatment centre.

The congress opens with the Allied Health Professionals Day for nurses, physiotherapists and psychosocial professionals. Its joint session looks at how new treatments are changing care, including factor versus non-factor treatment and gene therapy, while dedicated sessions address frailty, PROMs and PREMs, outreach programmes, needle-related anxiety and pain-related trauma. An Ultrasound Workshop is also part of the programme. Abstract submission and early-bird registration are open on the congress website.

For related clinical guidance, see the medpresso overview of The European guideline on management of major bleeding and coagulopathy following trauma.

*Please note that medpresso.org is an independent entity and is not associated with the official organization of this event. Please refer to the official website through the provided link for additional information.